PWA
TNGX icon

Physician Wealth Advisors’s Tango Therapeutics TNGX Stock Holding History

Physician Wealth Advisors’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$563 Buy
+18
New +$445 ﹤0.01% 2058
2025
Q2 		– Sell
-568
Closed -$779 – 1971
2025
Q1 		$779 Buy
+568
New +$1.4K ﹤0.01% 1241

Other funds holding TNGX

CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
DACS
Dymon Asia Capital (Singapore) Singapore $2.39B AUM 150.5% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
TFM
TFC Financial Management Boston, Massachusetts $902M AUM 21.74% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Physician Wealth Advisors's TNGX Position: Q2 2026 in Review

Physician Wealth Advisors opened a new position in Tango Therapeutics (TNGX) in Q2 2026: 18 shares worth $563. The stake represents ﹤0.01% of the portfolio and ranks #2058 among its holdings. This is a return to the name: Physician Wealth Advisors previously reported a position in TNGX as recently as Q1 2025.

Physician Wealth Advisors first reported a position in TNGX in Q1 2025 and has held it in 2 quarters since. The position peaked at $779 in Q1 2025. 18 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Physician Wealth Advisors held 18 shares of Tango Therapeutics worth $563 as of Q2 2026.
  • Tango Therapeutics was a new Physician Wealth Advisors position in Q2 2026.
  • Tango Therapeutics made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #2058 holding.
  • Physician Wealth Advisors first reported a position in Tango Therapeutics in Q1 2025 and has held it in 2 quarters since.
  • Physician Wealth Advisors's Tango Therapeutics position peaked at $779 in Q1 2025.
  • 18 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.